| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = -$553,010 ) |
| | 2024 | 2024 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | R01DK138466 | Understanding the Interaction between Host Genetics, Immune response, and Gut Microbes in Post-operative Recurrence of Crohn's disease | 000 | 1 | NIH | 2/5/2024 | $324,000 |
| | 2024 | 2024 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | R21AG080575 | Discovery and validation of biomarkers of autoimmunity in Alzheimer's Disease. | 002 | 2 | NIH | 12/15/2023 | $205,238 |
| | 2024 | 2023 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | U01DK062423 | Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes | 000 | 22 | NIH | 12/15/2023 | $0 |
| | 2024 | 2022 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | R01OD010929 | BioGRID: An open resource for biological interactions and network analysis | 001 | 16 | NIH | 2/27/2024 | -$295,621 |
| | 2024 | 2022 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | R01OD010929 | BioGRID: An open resource for biological interactions and network analysis | 000 | 16 | NIH | 2/27/2024 | -$786,628 |
|
| Issue Date FY: 2023 ( Subtotal = $307,844 ) |
| | 2023 | 2022 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | U01DK062423 | Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes | 004 | 21 | NIH | 5/4/2023 | $0 |
| | 2023 | 2022 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | U01DK062423 | Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes | 003 | 21 | NIH | 2/23/2023 | $404,685 |
| | 2023 | 2020 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | U01DK062423 | Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes | 001 | 19 | NIH | 2/23/2023 | -$96,841 |
|
| Issue Date FY: 2022 ( Subtotal = $1,293,149 ) |
| | 2022 | 2022 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | U01DK062423 | Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes | 001 | 21 | NIH | 9/20/2022 | $1 |
| | 2022 | 2022 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | R01OD010929 | BioGRID: An open resource for biological interactions and network analysis | 003 | 16 | NIH | 7/7/2022 | $353,229 |
| | 2022 | 2022 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | R01OD010929 | BioGRID: An open resource for biological interactions and network analysis | 002 | 16 | NIH | 7/6/2022 | $939,919 |
| | 2022 | 2021 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | R01OD010929 | BioGRID: An open resource for biological interactions and network analysis | 001 | 15 | NIH | 1/19/2022 | $263,458 |
| | 2022 | 2020 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | R01OD010929 | BioGRID: An open resource for biological interactions and network analysis | 000 | 14 | NIH | 1/19/2022 | -$263,458 |
| | 2022 | 2020 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | R01HD089660 | Lipidomics: A Novel Tool to Define Human Placental Development and Function Across Pregnancy | 000 | 5 | NIH | 1/5/2022 | $0 |
| | 2022 | 2016 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | U01DK062423 | Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes | 000 | 15 | NIH | 10/1/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,248,711 ) |
| | 2021 | 2021 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | R01OD010929 | BioGRID: An open resource for biological interactions and network analysis | 001 | 15 | NIH | 7/7/2021 | $942,594 |
| | 2021 | 2021 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | U01DK062423 | Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes | 000 | 20 | NIH | 8/31/2021 | $307,844 |
| | 2021 | 2020 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | R01OD010929 | BioGRID: An open resource for biological interactions and network analysis | 000 | 14 | NIH | 7/6/2021 | $0 |
| | 2021 | 2018 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | | | CAN | F32DK107050 | Investigation of the Therapeutic Potential of Fibroblast Activation Protein Inhibition in Type 2 Diabetes | 000 | 3 | NIH | 12/28/2020 | -$1,727 |
|
| Issue Date FY: 2020 ( Subtotal = $1,606,995 ) |
| | 2020 | 2020 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | R01OD010929 | BioGRID: An open resource for biological interactions and network analysis | 000 | 14 | NIH | 5/20/2020 | $895,351 |
| | 2020 | 2020 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | R01HD089660 | Lipidomics: A Novel Tool to Define Human Placental Development and Function Across Pregnancy | 000 | 5 | NIH | 7/9/2020 | $397,649 |
| | 2020 | 2020 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | U01DK062423 | Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes | 001 | 19 | NIH | 8/18/2020 | $313,995 |
| | 2020 | 2019 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | U01DK062423 | Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes | 000 | 18 | NIH | 11/27/2019 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,730,887 ) |
| | 2019 | 2019 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | R01HD089660 | Lipidomics: A Novel Tool to Define Human Placental Development and Function Across Pregnancy | 000 | 4 | NIH | 8/26/2019 | $397,649 |
| | 2019 | 2019 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | R01OD010929 | BioGRID: An open resource for biological interactions and network analysis | 001 | 13 | NIH | 6/6/2019 | $895,351 |
| | 2019 | 2019 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | U01DK062423 | Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes | 000 | 18 | NIH | 8/23/2019 | $329,910 |
| | 2019 | 2019 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | U01DK062423 | Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes | 001 | 18 | NIH | 9/12/2019 | $107,977 |
| | 2019 | 2019 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | U01DK062423 | Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes | 002 | 18 | NIH | 9/13/2019 | $107,977 |
| | 2019 | 2019 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | U01DK062423 | Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes | 002 | 18 | NIH | 9/13/2019 | -$107,977 |
| | 2019 | 2015 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | R01OD010929 | BioGRID: An open resource for biological interactions and network analysis | 000 | 9 | NIH | 1/7/2019 | $0 |
| | 2019 | 2014 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | DP3DK104386 | Multinational Collaborative Evaluation of Corneal Confocal Microscopy as a Surrogate Endpoint for the Identification and Prediction of Diabetic Neuropathy in Type 1 Diabetes | 000 | 1 | NIH | 1/7/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $1,701,108 ) |
| | 2018 | 2018 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | U01DK062423 | Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes | 002 | 17 | NIH | 9/10/2018 | $316,114 |
| | 2018 | 2018 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | R01OD010929 | BioGRID: An open resource for biological interactions and network analysis | 000 | 12 | NIH | 7/16/2018 | $895,351 |
| | 2018 | 2018 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | U01DK062423 | Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes | 003 | 17 | NIH | 9/18/2018 | $107,825 |
| | 2018 | 2018 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | F32DK107050 | Investigation of the Therapeutic Potential of Fibroblast Activation Protein Inhibition in Type 2 Diabetes | 001 | 3 | NIH | 8/24/2018 | $9,850 |
| | 2018 | 2018 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | R01HD089660 | Lipidomics: A Novel Tool to Define Human Placental Development and Function Across Pregnancy | 000 | 3 | NIH | 7/19/2018 | $371,968 |
| | 2018 | 2017 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | U01DK062423 | Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes | 001 | 16 | NIH | 1/4/2018 | $50,245 |
| | 2018 | 2016 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | U01DK062423 | Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes | 000 | 15 | NIH | 1/4/2018 | -$50,245 |
|
| Issue Date FY: 2017 ( Subtotal = $1,543,379 ) (Continued on the next page) |
| | 2017 | 2017 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | F32DK107050 | Investigation of the Therapeutic Potential of Fibroblast Activation Protein Inhibition in Type 2 Diabetes | 001 | 2 | NIH | 9/6/2017 | $8,850 |
| | 2017 | 2017 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | U01DK062423 | Impact of Genetic Variability on Cellular Pathways and Host-Microbiome Interactio | 000 | 16 | NIH | 9/19/2017 | $311,979 |
| | 2017 | 2017 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | R01OD010929 | BioGRID: An open resource for biological interactions and network analysis | 001 | 11 | NIH | 9/11/2017 | $44,767 |
| | 2017 | 2017 | SINAI HEALTH SYSTEM | 600 UNIVERSITY AVE | TORONTO | ON | M5G 1X5 | | CAN | R01HD089660 | Lipidomics: A Novel Tool to Define Human Placental Development and Function Across Pregnancy | 000 | 2 | NIH | 8/1/2017 | $371,968 |
|
